| GENOWAY S.A. INH. EO-,60 |
| Frankreich |
| Gesundheit |
| FR0004053510 / A0MRJ4 |
| JEH (Frankfurt) |
| FRA:JEH, ETR:JEH, JEH:GR |
| - |
| http://www.genoway.com/ |
|
Genoway S.A. is a specialized biotechnology company that develops and markets genetically modified animal models for research purposes. Its primary function is to provide customized and innovative solutions for pharmaceutical companies, academic inst..
>Volltext.. |
| 30.83 Mio. EUR |
| 28.72 Mio. EUR |
| 21.34 Mio. EUR |
| - |
| 1.29 Mio. EUR |
| 0.2 EUR |
| - |
| 2.16 Mio. EUR |
| - |
| - |
| -2.21% |
| 0.91% |
| - |
| - |
| - |
| - |
| GENOWAY |
| 01.04.26 |
|